Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00059319 · ClinicalTrials.gov registry record · Phase 3
Reduced Manipulation of the Aorta and Neurobehavioral Outcome Trial
A Phase 3 study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
NCT00059319 is a Phase 3 study that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 300 participants.
The verdict
NCT00059319, a Phase 3 study, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine whether aortic manipulation in patients undergoing coronary bypass graft surgery leads to increased incidence of microemboli and subsequent impairment of neurobehavioral function.
Interventions
- PROCEDURE single aorta clamp with retrograde cardioplegia
- PROCEDURE multiple aorta clamps with antegrade cardioplegia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 1999-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00059319
The ClinicalTrials.gov registry entry for NCT00059319 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which single aorta clamp with retrograde cardioplegia is the first listed.
NCT00059319 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00059319 about?
NCT00059319 is a clinical study titled "Reduced Manipulation of the Aorta and Neurobehavioral Outcome Trial". The purpose of this trial is to determine whether aortic manipulation in patients undergoing coronary bypass graft surgery leads to increased incidence of microemboli and subsequent impairment of neurobehavioral function.
What is the current status of trial NCT00059319?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 1999-01.
What interventions are being tested in trial NCT00059319?
The interventions under investigation include: single aorta clamp with retrograde cardioplegia (PROCEDURE), multiple aorta clamps with antegrade cardioplegia (PROCEDURE).
Who is sponsoring clinical trial NCT00059319?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.